Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/23/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Arthur DeCarlo DDS PhD

Wrong Dr. Arthur DeCarlo DDS PhD?

President and Chief Executive Off...

Local Address: Birmingham, Alabama, United States
BONENTA Inc
P.O. Box 430021
Cahaba Heights , Alabama 35243
United States

Company Description: Bonenta is developing novel drug-eluting synthetic bone grafts that will dominate the industry with the safest, most effective bone healing technology. Bonenta,...   more
Background

Employment History

Education

  • Ph.D. , Biochemistry & Molecular Genetics
  • Ph.D. training
    University of Alabama
  • DDS
24 Total References
Web References
BONENTA, Inc.
www.bonenta.com, 23 Mar 2015 [cached]
Leadership: Dr. Arthur DeCarlo, President and CEO, Director
BONENTA, Inc.
www.bonenta.com, 23 Mar 2015 [cached]
Dr. Arthur DeCarlo, Bonenta's founder, President, and current CEO, received his Ph.D. training and medical specialty training at the University of Alabama in Birmingham under world-class mentorship. He has spent 23 years acquiring expertise in surgical clinical medicine, biochemistry, genetics, microbiology, and immunological research and has a proven experience in conveying the scientific knowledge and information necessary to garner peer-reviewed research approvals, funding awards and publications. Dr. DeCarlo has also spent several years on committees that oversee research in human subjects (IRB and Clinical Trial Safety Review Board), has directed pre-clinical and human clinical research, and chaired university health professions research activities. International experience has provided a broader scientific perspective to an already award-winning research career. Dr. DeCarlo participated in the NIH Commercialization Accelerator Program (CAP) program in 2008-09.
...
Dr. Whitelock and Dr. DeCarlo discuss data monthly and meet annually.
...
Dr. Chambers and Dr. DeCarlo have also worked well together in the past, exchanging ideas freely.
...
A pre-IND meeting will be scheduled immediately following a financing event and will be attended by Dr. DeCarlo and Lindsay Donald.
Agenta Biotechnologies
www.agentabio.com, 25 Oct 2012 [cached]
Arthur DeCarlo, DDS, Ph.D. President and Science Director, Agenta
...
President and CEO: Dr. Arthur DeCarlo
...
Secretary: Dr, Arthur DeCarlo
...
Dr. Arthur DeCarlo
Agenta Biotechnologies
www.agentabio.com, 25 Oct 2012 [cached]
Dr. Arthur DeCarlo , President, CEO
...
Dr. Arthur DeCarlo
...
Dr. Arthur DeCarlo Full-time Research Scientist Science Director Agenta Biotechnologies
The President and founder of Agenta Biotechnologies, Inc., Dr. Arthur DeCarlo, is a former clinician, and academician, with a Ph.D. in Biochemistry & Molecular Genetics ('94) who currently oversees the scientific and development aspects of the business as a full-time employee of Agenta.
Dr. DeCarlo received his Ph.D. training at the University of Alabama in Birmingham. Dr. DeCarlo has spent more than a decade acquiring expertise and experience in surgical clinical medicine, biochemistry, genetics, microbiology, and immunological research. He has a proven experience in conveying the scientific knowledge and information necessary to garner peer-reviewed publications, research approvals, and elite funding awards. Dr. DeCarlo has also spent several years on committees that oversee research in human subjects (IRB), and served as Chairman of the Health Professions Research at Nova Southeastern University, a position since filled by Dr. Patrick Hardigan.
Agenta Biotechnologies
www.agentabiotechnologies.com, 1 Mar 2011 [cached]
October, 2010: Agenta's technology was presented by Dr. DeCarlo at the American Society for Matrix Biology meeting in Charleston, SC.
...
Dr. DeCarlo, CEO of Bonenta, Inc., is representing Bonenta, Inc. in this prestigious program.
...
"We know that heparan sulfate and growth factors play a vital role in the healing process, so we are very pleased that Perl.D1 has demonstrated effectiveness in bone repair," stated Dr. Arthur DeCarlo, Agenta's President and Chief Scientific Officer.
...
September 20, 2007: Dr. Arthur DeCarlo was nominated and accepted into the Birmingham Venture Club Accelerator Program.
...
April 10th, 2007: Dr. DeCarlo, President and Science Director of Agenta Biotechnologies, Inc., met with investors and industry representa at the 2007 BioWindhover meeting in our nation's capitol regarding Agenta's Therapeutic Proteoglycan DNA Delivery platform and early-stage pipeline therapeutics for treatment Alzheimer's disease and for the treatment of damaged skin, including wrinkles.
Other People with the name "DeCarlo":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.